Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2015-10-08 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
104年9月營業收入
Regulatory Filings Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 景岳 for the period 民國104年09月 (September 2015). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document length is only 764 characters, which is very short and contains no detailed financial statements or analysis. It appears to be a regulatory disclosure or a summary report rather than a full financial report like an Annual Report (10-K) or Interim Report (IR). There is no indication of it being an earnings release or investor presentation. Given the short length and summary nature, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2015-10-08 Chinese
104年09月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, changes in holdings, and related information. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial results, management discussion, or other report types. The document is not a report publication announcement or a certification. Therefore, it fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades).
2015-10-07 Chinese
104年09月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and executives, showing their current holdings, pledged shares, and related percentages. It is focused on insider share ownership and pledging status rather than financial results, management changes, or meeting materials. There is no indication of a report or announcement of voting results, dividends, or capital changes. The content aligns with a Director's Dealing or insider shareholding disclosure. Given the detailed insider shareholding data, this fits best under Major Shareholding Notification (MRQ), which covers notifications of significant share ownership levels and insider holdings. The document length is moderate and contains substantive data, not just an announcement or certification, so it is not RNS or RPA. Therefore, the classification is MRQ with high confidence.
2015-10-07 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (景岳生物科技股份有限公司) regarding the commitments made when applying for stock listing transfer from OTC to main board and the subsequent execution status as of the third quarter of 2015 (104/10/01 in ROC calendar). It references compliance with Taiwan Stock Exchange regulations and details about auditor commitments and financial reporting. The document is short (799 characters) and primarily serves as a regulatory disclosure of compliance status rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2015-10-01 Chinese
104年8月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (770 characters), and it appears to be a brief financial data summary rather than a full report or announcement. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is best classified as Fund Information / Factsheet (FS) because it provides a brief summary of key financial figures and related notes.
2015-09-10 Chinese
104年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is very short (601 characters) and contains tabular data about the company's and subsidiaries' financial guarantees and loan balances, all showing zero values. There is no indication of a full financial report, management discussion, or detailed financial statements. The content resembles a regulatory disclosure or compliance update rather than a full report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a certification or officer attestation. Given the nature and length, it is best classified as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2015-09-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.